Viewing Study NCT00243035


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-02-28 @ 9:05 PM
Study NCT ID: NCT00243035
Status: TERMINATED
Last Update Posted: 2013-10-08
First Post: 2005-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Multiple Myeloma View
None Stage II Multiple Myeloma View
None Stage III Multiple Myeloma View
Keywords: